Wiley Bros. Aintree Capital, LLC Elanco Animal Health Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $12.5 Billion
- Q2 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 28,113 shares of ELAN stock, worth $622,702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,113
Previous 24,645
14.07%
Holding current value
$622,702
Previous $258,000
55.43%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ELAN
# of Institutions
439Shares Held
486MCall Options Held
868KPut Options Held
1.42M-
Dodge & Cox San Francisco, CA82.9MShares$1.84 Billion0.71% of portfolio
-
Primecap Management CO Pasadena, CA51.8MShares$1.15 Billion0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA47.8MShares$1.06 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$516 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX22.7MShares$504 Million0.08% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $10.5B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...